BridgeBio Oncology Therapeutics: Executives
Yong Ben, M.D., M.B.A.Chief Medical and Development OfficerFY2024
Eli Wallace, Ph.D.Former President and Chief Executive OfficerNot disclosed—
Uneek Mehra, M.B.A.Former Chief Financial OfficerNot disclosed—
3 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.